LeMaitre Vascular, Inc. (LMAT)
NASDAQ: LMAT · Real-Time Price · USD
80.82
+1.82 (2.30%)
Aug 6, 2026, 4:00 PM EDT - Market closed
LeMaitre Vascular Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Income | 65.67 | 57.73 | 44.04 | 30.11 | 20.64 | 26.91 |
Depreciation & Amortization | 10.5 | 10.42 | 9.61 | 9.52 | 9.43 | 11.07 |
Stock-Based Compensation | 7.86 | 7.83 | 6.57 | 5.32 | 4.17 | 3.48 |
Other Adjustments | 4.32 | 7.02 | 4.5 | 2.58 | 4.54 | 3.61 |
Change in Receivables | -0.53 | -2.95 | -6.42 | -3.14 | -3.53 | -0.82 |
Changes in Inventories | -5.7 | -7.22 | -10.57 | -9.79 | -7.42 | -5.49 |
Changes in Accounts Payable | -1.03 | 4.2 | -0.92 | 4.6 | 0.65 | -1.73 |
Changes in Accrued Expenses | -0.36 | 1.8 | 0.14 | - | - | - |
Changes in Other Operating Activities | -0.61 | 2.43 | -2.33 | -2.92 | -3.1 | -1.93 |
Operating Cash Flow | 82.98 | 81.25 | 44.12 | 36.75 | 25.38 | 35.1 |
Operating Cash Flow Growth | 41.22% | 84.14% | 20.06% | 44.81% | -27.70% | 0.87% |
Capital Expenditures | -9.15 | -6.78 | -6.96 | -7.27 | -3.23 | -4.88 |
Sale of Property, Plant & Equipment | - | - | - | - | 0.86 | - |
Purchases of Investments | -854.91 | -641.33 | -277.94 | -16.55 | -8 | -59.19 |
Proceeds from Sale of Investments | 797.56 | 585.07 | 84.78 | - | - | 3 |
Cash Acquisitions | -1.96 | -1.9 | - | -0.9 | - | - |
Investing Cash Flow | -68.47 | -64.94 | -200.12 | -24.72 | -10.37 | -61.08 |
Long-Term Debt Issued | - | - | 169.27 | - | - | - |
Long-Term Debt Repaid | - | - | - | - | - | -39 |
Net Long-Term Debt Issued (Repaid) | - | - | 169.27 | - | - | -39 |
Issuance of Common Stock | 7.48 | 6.82 | 6.44 | 6.17 | 3.47 | 63.24 |
Repurchase of Common Stock | -1.69 | -1.82 | -1.72 | -0.85 | -0.64 | -0.8 |
Net Common Stock Issued (Repurchased) | 5.79 | 5 | 4.72 | 5.32 | 2.82 | 62.44 |
Common Dividends Paid | -20.5 | -18.11 | -14.38 | -12.45 | -10.99 | -9.34 |
Other Financing Activities | -0.1 | -1.43 | -1.51 | - | -1.07 | -0.4 |
Financing Cash Flow | -14.81 | -14.54 | 158.1 | -7.13 | -9.23 | 13.7 |
Foreign Exchange Rate Adjustments | -0.25 | 0.86 | -0.77 | 0.23 | -0.49 | -0.64 |
Net Cash Flow | -0.55 | 2.63 | 1.34 | 5.14 | 5.28 | -12.91 |
Free Cash Flow | 73.83 | 74.47 | 37.16 | 29.49 | 22.15 | 30.22 |
Free Cash Flow Growth | 41.11% | 100.39% | 26.03% | 33.13% | -26.71% | -5.02% |
FCF Margin | 28.13% | 29.83% | 16.90% | 15.24% | 13.70% | 19.57% |
Free Cash Flow Per Share | 3.11 | 3.25 | 1.63 | 1.31 | 1.00 | 1.41 |
Levered Free Cash Flow | 59.32 | 62.57 | 202.27 | 24.24 | 16.97 | -15.05 |
Unlevered Free Cash Flow | 53.57 | 56.98 | 29.42 | 22.13 | 16.47 | 25.63 |